GlassScriptPhysician profile
Thomas A Beck
NPI 1962855056
$1,403.56
in general payments reported to CMS, 2019-2025
9 companies · $679 in 2025
The $679 reported for 2025 was more than what a typical Podiatrist provider received nationally (typical 2025 total: $260).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $267 · 2020: $223 · 2021: $132 · 2022: $12.31 · 2024: $91.09 · 2025: $679.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $685 · Travel and Lodging: $84.96.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $684.81 |
| Travel and Lodging | $84.96 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Stryker Corporation | $788.03 | 2019-2025 | Variax, Citrefix, Anchorage |
| Zyla Life Sciences, INC. | $202.25 | 2019 | |
| Paragon 28, INC. | $149.65 | 2025 | Precision Mis Bunion, Portfolio |
| Orthofix Medical, INC. | $79.66 | 2025 | Physio-Stim |
| Ortho Dermatologics, A Division of Bausch Health US, LLC | $68.51 | 2020-2022 | |
| Smith+Nephew, INC. | $56.18 | 2024-2025 | Grafix Pl, Grafix, Stravix |
| Melinta Therapeutics, LLC | $26.83 | 2019 | |
| Mimedx Group, INC. | $18.97 | 2024 | |
| Solventum Corporation | $13.48 | 2025 | Activ.A.C., Snap |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Thomas Beck listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.